key: cord-0908687-x7v73606
authors: Fu, Shuai; Cheng, Rongrong; Xiang, Zilei; Deng, Zixin; Liu, Tiangang
title: Rapid Profiling of Chemical Constituents in Qingfei Paidu Granules Using High Performance Liquid Chromatography Coupled with Q Exactive Mass Spectrometry
date: 2021-09-12
journal: Chromatographia
DOI: 10.1007/s10337-021-04085-0
sha: 1034568c3ee74aff19762171b4752b4f21df083f
doc_id: 908687
cord_uid: x7v73606

Qingfei Paidu (QFPD) granules have played a critical role during the Coronavirus Disease 2019 (COVID-19) in China. However, worldwide acceptance has been a problem because of the complex ingredients and unique theory of treatment. In this study, high-performance liquid chromatography (HPLC)-Q Exactive Orbitrap-mass spectrometry (MS) and the Orbitrap traditional Chinese medicine library (OTCML) were used to investigate the chemical constituents of QFPD granules. By comparing retention times, masses, isotope ion patterns, and MS(2) profiles, 108 compounds were putatively identified using the OTCML combined with manual verification, including 12 alkaloids, 49 flavonoids, 13 terpenoids, 14 phenylpropanoids, 4 phenolic acids, 5 phenols, and 11 other phytochemicals. Of these compounds, 17 were confirmed using reference standards. In addition, representative compounds of these different chemical types were used as examples to analyze the fragmentation pathways and characteristic product ions. Moreover, 20 herbs within the QFPD granules were also identified to establish the sources of these chemical components. This is the first rapid profiling of the chemical constituents of QFPD granules using HPLC-Q Exactive Orbitrap-MS and yields valuable information for further quality control and mechanistic studies of QFPD granules. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10337-021-04085-0.

Qingfei Paidu (QFPD) granules and decoctions are effective traditional Chinese medicines (TCMs) that are included in the Guidelines for Diagnosis and Treatment of COVID-19 Pneumonia, issued by the National Heath Commission of the [1] . Functional network pharmacology analysis units showed that QFPD protected against COVID-19 through anti-viral and anti-inflammatory activities [2] . A systematic pharmacological study illustrated that QFPD exhibited immune regulation, anti-infection and anti-inflammatory properties, and multi-organ protection [3] . QFPD granules were, therefore, approved for market use by the National Medical Products Administration in China [4] . However, worldwide acceptance of QFPD granules is challenging because of the TCM complexity, and unique theory of treatment, in addition to quality and safety issues [5, 6] . Thus, comprehensive identification of the chemical components of QFPD granules is extremely critical for quality control, in addition to identification of the active ingredients and investigation of the mechanism-of-action.

Few analytical strategies have been applied to study the chemical constituents of QFPD decoctions, and no detailed analysis of the chemical composition of QFPD granules has been reported [7] [8] [9] . Hybrid quadrupole-Orbitrap mass spectrometry (MS) is a powerful tool for structure elucidation of TCMs due to its high resolution and high-quality MS 2 fragmentation patterns. In this study, high-performance liquid chromatography (HPLC)-Q Exactive Orbitrap-MS was used to analyze the chemical constituents of QFPD granules, with 108 compounds putatively identified, including 12 alkaloids, 49 flavonoids, 13 terpenoids, 14 phenylpropanoids, 4 phenolic acids, 5 phenols, and 11 other phytochemicals. The individual herbs within the QFPD granules were also analyzed. The aim of this study is to develop an analytical method for elucidating the chemical constituents of QFPD granules and provide valuable quality control and mechanism-of-action data.

QFPD granules were a gift from Renmin Hospital of Wuhan University. The 21 raw materials were purchased from Yifeng Pharmacy Chain Co., Ltd. (Changde, China). Acetonitrile (HPLC grade) and methanol (HPLC grade) were purchased from Merck (Darmstadt, Germany). Formic acid was purchased from Thermo Fisher Scientific (Waltham, MA, USA). Watsons distilled water was obtained from Jingdong Mall (Beijing, China).

Authentic standards of cytosine, sucrose, citric acid, uridine, adenosine, 2-pyrrolidinecarboxylic acid, and guanosine were purchased from Sigma-Aldrich (St. Louis, MO, USA). Nicotinic acid was obtained from Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China). Nicotinamide and tangeretin were purchased from Shanghai Aladdin Bio-Chem Technology Co., Ltd. (Shanghai, China). Salicylic acid was acquired from Ascender Chemical Co., Ltd. (Shanghai, China). Glycyrrhizic acid, 18-β-glycyrrhetinic acid, isoliquiritigenin, baicalin, and narirutin were purchased from Shanghai Macklin Biochemical Co., Ltd. (Shanghai, China). Chlorogenic acid was a gift from Thermo Fisher Scientific.

The QFPD granules were ground, and the resultant powder (0.4 g) was accurately weighed, dissolved in 60% methanol (v/v; 20 mL), and sonicated for 30 min, resulting in partial precipitation of the QFPD granules. The solution was centrifuged, and the supernatant was filtered through a 0.22 μm membrane prior to HPLC-Q Exactive Orbitrap-MS.

The individual raw materials were treated using the same procedure.

The authentic standards were dissolved in 50% methanol and stored at -80 ℃. Prior to qualitative analysis, they were mixed appropriate concentrations and filtered using a 0.22 μm membrane.

LC-MS was performed using an UltiMate 3000 UPLC system (Thermo Fisher Scientific), autosampler, a vacuum degasser, binary pump, and column compartment. A Hypersil Gold aQ C18 column (2.1 × 150 mm, 3 μm) was used at 40 ℃ for chromatography. The mobile phase consisted of acetonitrile/0.1% formic acid (A) and water/0.1% formic acid (B) at a flow rate of 0.2 mL/min. The following gradient elution program was used: 0-2 min, 0-5% (A); 2-42 min, 5-95% (A); 42-46.9 min, 95% (A); 46.9-47 min, 95-5% (A); 47-50 min, 5% (A). The total run time was 50 min, and the sample injection volume was 5 μL.

A Q Exactive hybrid quadrupole-Orbitrap mass spectrometer (Thermo Fisher Scientific) with heated electrospray ionization (ESI) was used. Source parameters were optimized with a spray voltage of 3.5 kV ( +)/3.2 kV (−). The other parameters were set as follows: capillary temperature, 320 ℃; auxiliary gas temperature, 350 ℃; sheath gas, 40 Arb; auxiliary gas, 15 Arb; sweep gas, 0 Arb; S-lens RF level, 50.

The Orbitrap mass detector was operated in full scan plus data-dependent MS 2 mode. The MS resolution was set at 70,000 for the full scan and 17,500 for the MS 2 scan. The automatic gain control target and maximum injection time were 1 × 10 6 ions capacity and 100 ms, respectively. The top N (N: the number of most abundant ions for fragmentation) was five, while the scan range was m/z 100-1500. The normalized collision energies were 20%, 40%, and 60%, and the isolation window was 1.2 Da. The apex trigger was 5-15 s, and the loop count was 3. The dynamic exclusion was 5 s.

The raw data were imported into the Compound Discoverer (CD) software, which is integrated into the OTCML. The molecular masses, retention times, fragments, and peak areas from both the positive and negative ESI modes were compared to the mzVault library, which was integrated into CD. The mzVault spectral library (Thermo Fisher Scientific) contained the retention times, precise mass ions, and MS 2 fragments of 1200 commercial reference standards, which were analyzed using Q Exactive Orbitrap-MS. The software identified peaks with high mass accuracy (< 10 ppm) and an isotope pattern variation within 85%. The molecular compositions adhered to the H/C ratio rules and were matched to potential compounds using ring and double-bond equivalents. The MS 2 profiles were compared with the reference spectra from the mzVault library. Compounds were identified only when the match score was > 85. In addition, compound identification accuracy was improved by comparing the obtained data and possible fragmentation patterns with those in the literature, and the corresponding individual herb pieces components were analyzed to determine the source of each compound and elucidate chemical compositions.

Positive and negative ion modes were used to detect the chemical compounds within the QFPD granules. The base peak chromatograms (BPCs) of the QFPD granules are shown in Fig. 1 . In total, 108 compounds are putatively identified ( Table 1 ). The BPCs of the individual herb pieces are shown in Figs. S1 and S2. Compound identification is summarized below. Compounds 3 (cytosine), 7 (nicotinic acid), and 9 (nicotinamide) were identified by comparing the retention times and MS 2 fragmentation patterns with those of reference The spectra are very similar, and the compounds were identified using the OTCML by the different retention times and slight differences in the spectra. Compound 102 (tangeretin) was further confirmed using a reference standard. Compounds 30 and 33 showed similar MS 2 patterns, but the molecular ions were different, indicating the same basic structure. These compounds were assigned as vicenin II [8] and isoschaftoside [20, 33] , respectively. For example, the mass spectrum of com- [19] , and baicalin (61) was identified using a reference standard. Based on the literature [26] , compounds 73 and 100 were assigned as hesperetin and heptamethoxyflavone, respectively. Compound 79 (isoliquiritigenin) was identified using a reference standard.

Fourteen compounds were identified as phenylpropanoids. 

Four phenolic acids were identified, and they exhibited the same fragmentation pattern. [36] . Compound 87 displays a similar fragmentation pattern, yet is 16 Da smaller than compound 82. Compound 87 was then confirmed as glycyrrhizic acid through a comparison between the negative ESI mode data, a reference standard, and literature data [20] . These spectra are shown in Fig.S6 

Eleven compounds were identified by comparing the obtained data to the information in the OTCML, including the hydrophilic compounds 1 (sucrose), 2 (2-pyrrolidinecarboxylic acid), 6 (citric acid), 8 (uridine), 10 (adenosine) and 11 (guanosine). These compounds were also confirmed using reference standards.

The extracted ion chromatograms (EICs) of 17 authentic standards compared with those of their corresponding detected compounds within QFPD granules are shown in Fig. 2 . The HPLC-Q Exactive hybrid quadrupole-Orbitrap MS method was also used for quantification analysis of these 17 constituents within QFPD granules. The concentration of each constituent was obtained using the respective calibration curve and their contents within the QFPD granules are listed in Table 2 .

In total, 265 compounds were putatively identified using the OTCML combined with manual verification from 20 herbs that are components of QFPD granules (Table S1) , including 33 alkaloids, 106 flavonoids, 28 terpenoids, 41 phenylpropanoids, 10 phenolic acids, 18 phenols and 29 other phytochemicals. Of these, 163 compounds were from only one herb, and 102 compounds were from more than two herbs. Within the QFPD granules, 59 compounds were from only one herb and 49 compounds were from more than two herbs.

In this study, HPLC-Q Exactive hybrid quadrupole-Orbitrap MS coupled with the OTCML which is an automatic data analysis platform, was used to study the chemical profile of QFPD granules, an effective TCM prescribed to treat the symptoms of SARS-CoV-2 infections. Furthermore, manual verification ensured compound identification. A total of 108 compounds were putatively identified from QFPD granules, including alkaloids, flavonoids, phenylpropanoids, phenolic acids, phenols, terpenoids and other phytochemicals. This allowed rapid chemical composition screening of QFPD granules, providing potentially valuable information for quality control and further clinical application.

The online version contains supplementary material available at https:// doi. org/ 10. 1007/ s10337-021-04085-0. 

Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform, Compilation prepared by

The authors declare that there are no conflicts of interest.

We certify that this manuscript is original, has not been previously published and will not be submitted elsewhere for publication while under consideration by Chromatographia. This study is not split into several parts and submitted to various journals. Results are presented clearly, honestly and without fabrication. No data, text, or theories by others are presented as our own.Human and Animal Rights Explicit permission to submit has been received from all co-authors. All the authors whose name appear on the submission have contributed sufficiently to this study.This manuscript does not contain any studies involving humans or animals.